Meta-analysis: Cardiac resynchronization therapy for patients with less symptomatic heart failure

Annals of Internal Medicine

Volumn 154, Issue 6, 2011, Pages 401-412

  Al Majed, Nawaf S ^a   McAlister, Finlay A ^b   Bakal, Jeffrey A ^a   Ezekowitz, Justin A ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL (TOPIC); DEFIBRILLATOR; DISEASE CLASSIFICATION; EXERCISE TEST; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE; HEART VENTRICLE PACING; HOSPITALIZATION; HUMAN; INFECTION; META ANALYSIS; MORTALITY; NEW YORK HEART ASSOCIATION CLASSIFICATION; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PUBLICATION; QRS COMPLEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 79952822288     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-154-6-201103150-00313     Document Type: Review

References (65)

1. Writing Group Members, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215. [PMID: 20019324]
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al; ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933-89. [PMID: 18826876]
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-181. [PMID: 19075105].
4. Bueno H, Ross JS, Wang Y, Chen J, Vidán MT, Normand SL, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA. 2010;303:2141-7. [PMID: 20516414]
5. Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail. 2010. [PMID: 20959343]
6. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147:251-62. [PMID: 17709759]
7. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007;297:2502-14. [PMID: 17565085]
8. Howlett JG, McKelvie RS, Arnold JM, Costigan J, Dorian P, Ducharme A, et al; Canadian Cardiovascular Society. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol. 2009;25:85-105. [PMID: 19214293]
9. Heart Failure Society of America. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16:e1-194. [PMID: 20610207]
10. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al; American College of Cardiology Foundation. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1-e90. [PMID: 19358937]
11. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C, et al; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834-43. [PMID: 19038680]
12. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-38. [PMID: 19723701]
13. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385-95. [PMID: 21073365]
14. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, et al. 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail. 2010;12:1143-53. [PMID: 20965877]
15. Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006;48:2243-50. [PMID: 17161254]
16. Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48:2251-7. [PMID: 17161255]
17. Boriani G, Kranig W, Donal E, Calo L, Casella M, Delarche N, et al; B-LEFT HF Study Group. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial. Am Heart J. 2010;159:1052-1058. e1. [PMID: 20569719]
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. [PMID: 3802833]
19. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2. Updated September 2009. The Cochrane Collaboration; 2009. Accessed at www. cochrane-handbook.org on 4 January 2011.
20. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1-48. Accessed at www. jstatsoft.org/v36/i03/ on 4 January 2011.
21. Beshai JF, Grimm RA, Nagueh SF, Baker JH 2d, Beau SL, Greenberg SM, et al; RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357:2461-71. [PMID: 17986493]
22. Gasparini M, Bocchiardo M, Lunati M, Ravazzi PA, Santini M, Zardini M, et al; BELIEVE Investigators. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J. 2006; 152:155. e1-7. [PMID: 16824846].
23. Martinelli Filho M, de Siqueira SF, Costa R, Greco OT, Moreira LF, D'Avila A, et al. Conventional versus biventricular pacing in heart failure and bradyarrhythmia: the COMBAT study. J Card Fail. 2010;16:293-300. [PMID: 20350695]
24. Piepoli MF, Villani GQ, Corrà U, Aschieri D, Rusticali G. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity. Pacing Clin Electrophysiol. 2008;31: 701-8. [PMID: 18507542]
25. Rao RK, Kumar UN, Schafer J, Viloria E, De Lurgio D, Foster E. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation. 2007; 115:2136-44. [PMID: 17420340]
26. van Geldorp IE, Vernooy K, Delhaas T, Prins MH, Crijns HJ, Prinzen FW, et al. Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace. 2010;12:223-9. [PMID: 19966323]
27. Thibault B, Ducharme A, Harel F, White M, O'Meara E, Roy D, et al. Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms: The Greater-EARTH Trial. Presented at Heart Rhythm Society 31st Annual Scientific Sessions, Denver, Colorado, 13 May 2010.
28. U.S. Food and Drug Administration. St Jude Frontier cardiac resynchronization therapy pacing system. P030035/S3. Summary of safety and effectiveness [VecTOR]. 2005. Accessed at www. accessdata.fda.gov/cdrh_docs/pdf3/P030035S003b.pdf on 20 November 2010.
29. U.S. Food and Drug Administration. Summary of safety and effectiveness data. RHYTHM ICD. 2005. Accessed at www. accessdata.fda.gov/cdrh_docs/pdf3/P030054b.pdf on 20 November 2010.
30. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-80. [PMID: 11259720]
31. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346: 1845-53. [PMID: 12063368].
32. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al; Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026-33. [PMID: 12084604]
33. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002;23:1780-7. [PMID: 12419298]
34. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42:1454-9. [PMID: 14563591]
35. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-94. [PMID: 12771115]
36. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, et al; Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004;110:2864-8. [PMID: 15505095]
37. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50. [PMID: 15152059]
38. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49. [PMID: 15753115]
39. Kindermann M, Hennen B, Jung J, Geisel J, Böhm M, Fröhlig G. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol. 2006;47:1927-37. [PMID: 16697307]
40. Leclercq C, Cazeau S, Lellouche D, Fossati F, Anselme F, Davy JM, et al. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol. 2007;30 Suppl 1:S23-30. [PMID: 17302711]
41. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, et al; Pacing Therapies in Congestive Heart Failure II Study Group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109-16. [PMID: 14680736].
42. U.S. Food and Drug Administration. Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Clinical Report. 17 November 2009. Accessed at www. fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevices AdvisoryCommittee/CirculatorySystemDevicesPanel/UCM204611.pdf on 20 November 2010.
43. Lubitz SA, Leong-Sit P, Fine N, Kramer DB, Singh J, Ellinor PT. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. Eur J Heart Fail. 2010; 12:360-6. [PMID: 20335354]
44. Rector TS, Johnson G, Dunkman WB, Daniels G, Farrell L, Henrick A, et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87:VI71-7. [PMID: 8500243]
45. Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, et al; InSync/InSync ICD Italian Registry Investigators. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Am J Cardiol. 2007;100:1007-12. [PMID: 17826388]
46. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation. 2006;113:266-72. [PMID: 16401777]
47. St John Sutton M, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C, et al; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation. 2009;120:1858-65. [PMID: 19858419].
48. Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, et al; MADIT-CRT Investigators. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation. 2010;122:985-92. [PMID: 20733097]
49. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;301:1661-70. [PMID: 19383957]
50. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverterdefibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol. 2010;56:1133-9. [PMID: 20863954]
51. McAlister FA. Cardiac resynchronization therapy for heart failure: a hammer in search of nails [Editorial]. Circulation. 2008;118:901-3. [PMID: 18725501]
52. Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, et al. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess. 2007;11:iii-iv, ix-248. [PMID: 17999842]
53. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J. 2007;28:42-51. [PMID: 17110403]
54. Upadhyay GA, Choudhry NK, Auricchio A, Ruskin J, Singh JP. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2008;52:1239-46. [PMID: 18926327]
55. Hoppe UC, Casares JM, Eiskjaer H, Hagemann A, Cleland JG, Freemantle N, et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation. 2006;114:18-25. [PMID: 16801461]
56. Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR, et al; National Cardiovascular Data Registry. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. J Am Coll Cardiol. 2010;56:766-73. [PMID: 20797489]
57. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, et al; Scientific Committee. The European cardiac resynchronization therapy survey. Eur Heart J. 2009;30:2450-60. [PMID: 19723694]
58. Chung ES, Katra RP, Ghio S, Bax J, Gerritse B, Hilpisch K, et al. Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction _35%: a PROSPECT trial substudy. Eur J Heart Fail. 2010;12:581-7. [PMID: 20150328]
59. Maass AH, van Veldhuisen DJ. Device therapy in patients with heart failure and preserved ejection fraction (HFPEF): a new frontier? [Editorial]. Eur J Heart Fail. 2010;12:527-9. [PMID: 20498266]
60. Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, et al; Get With the Guidelines Steering Committee and Hospitals. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation. 2008;118:926-33. [PMID: 18697821]
61. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, et al. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation. 2010;121:1985-91. [PMID: 20421518]
62. Linde C, Abraham WT, Gold MR, Daubert C; REVERSE Study Group. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study. J Am Coll Cardiol. 2010;56:1826-31. [PMID: 21087711]
63. Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, et al. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009;158:956-64. [PMID: 19958862]
64. McAlister FA, Tu JV, Newman A, Lee DS, Kimber S, Cujec B, et al. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J. 2006;27: 323-9. [PMID: 16105850]
65. Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S, et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest. 2002;122:528-34. [PMID: 12171827]